X
Xiaomin Niu
Researcher at Shanghai Jiao Tong University
Publications - 53
Citations - 872
Xiaomin Niu is an academic researcher from Shanghai Jiao Tong University. The author has contributed to research in topics: Lung cancer & Medicine. The author has an hindex of 16, co-authored 39 publications receiving 677 citations. Previous affiliations of Xiaomin Niu include Shanghai Chest Hospital.
Papers
More filters
Journal ArticleDOI
FGFR1-ERK1/2-SOX2 axis promotes cell proliferation, epithelial-mesenchymal transition, and metastasis in FGFR1-amplified lung cancer.
TL;DR: It is revealed that activation ofFGFR1 promotes cell proliferation, EMT, and metastasis by the newly defined FGFR1-ERK1/2-SOX2 axis in FG FR1-amplified lung cancer.
Journal ArticleDOI
The histone acetylranseferase hMOF acetylates Nrf2 and regulates anti‐drug responses in human non‐small cell lung cancer
TL;DR: The role of MOF in human lung cancer and possible new substrates of hMOF are investigated.
Journal ArticleDOI
TERT Polymorphism rs2736100-C Is Associated with EGFR Mutation-Positive Non-Small Cell Lung Cancer
Rongrong Wei,Lan Cao,Hengying Pu,Hongwei Wang,Yonglan Zheng,Xiaomin Niu,Xiaoling Weng,Hong Zhang,Murray J. Favus,Lan-Jun Zhang,Wei Hua Jia,Yi Xin Zeng,Christopher I. Amos,Shun Lu,Hui Yun Wang,Yun Liu,Wanqing Liu +16 more
TL;DR: The study suggests that telomerase and telomere function may be essential for carcinogenesis of EGFRmut+ NSCLC and further investigation for the underlying mechanism is warranted.
Journal ArticleDOI
The Hippo/YAP1 pathway interacts with FGFR1 signaling to maintain stemness in lung cancer.
Tingting Lu,Ziming Li,Ying Yang,Wenxiang Ji,Yongfeng Yu,Xiaomin Niu,Qingyu Zeng,Weiliang Xia,Shun Lu +8 more
TL;DR: The data confirms that expression levels of YAP1 are positively associated with those of FGFR1 in clinical lung carcinoma samples as measured by real-time PCR, western blot, and immunohistochemistry (IHC) staining, and concludes that Yap1 is a potential therapeutic target for lung cancer.
Journal ArticleDOI
Clinical analysis of postoperative venous thromboembolism risk factors in lung cancer patients.
Yi Yang,Zhen Zhou,Xiaomin Niu,Ziming Li,Zhiwei Chen,Hong Jian,Xing-Hao Ai,Bai-jun Cheng,Meilin Liao,Shun Lu +9 more
TL;DR: Clinical risk factors for venous thromboembolism in postoperative lung cancer patients are explored in order to provide a basis for the prevention and treatment of postoperative VTE.